Endocrinologic factors in the design of more selective antitumor agents.
D000305:Adrenal Cortex Hormones / Q000037:antagonists & inhibitors; D000315:Adrenalectomy; D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D004339:Drug Compounding; D006728:Hormones / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D006728:Hormones